Healthcare -
Biotechnology - NASDAQ - US
$ 3.485
1.01 %
$ 660 M
Market Cap
-8.1
P/E
ABUS - TOTAL CURRENT ASSETS
Total Current Assets ABUS - Arbutus Biopharma Corporation
132 M
LAST VALUE
-9.35%
2 YEAR CAGR
0.43%
5 YEAR CAGR
6.50%
10 YEAR CAGR